Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
Clinical trial NCT05718934 · COMPLETED
Trial details
- NCT number
- NCT05718934
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2023-12-19
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.